文献速递免疫规划

火鸡疱疹病毒、CVI-988与SB-1单价及双价马立克病疫苗胚内接种加速肉型鸡先天性与细胞介导免疫应答的能力

Ability to accelerate innate and cell-mediated immune responses in meat-type chickens by in ovo vaccination with monovalent and bivalent Marek's disease vaccines.
PubMed 文献 · Vaccine · 2025-11-21

本研究在18胚龄对肉型鸡胚内接种火鸡疱疹病毒(HVT)、CVI-988或SB-1疫苗,评估先天性与适应性免疫应答,并观察CVI-988或SB-1与HVT的协同免疫增强效应。三种疫苗均显著增加脾脏γδ T细胞及CD4+CD28+、CD4+CD44+、CD8+CD28+、CD8+CD44+ T细胞频率,但组织嗜性、PHA-L驱动翅蹼厚度增加能力及部分免疫表型频率存在差异。作者认为三种疫苗似乎均增强一日龄肉型鸡的先天性和/或适应性应答,但疫苗的免疫协同作用需进一步研究。

要点

  • 18胚龄胚内接种HVT、CVI-988或SB-1均显著增加肉型鸡脾脏γδ T细胞及CD4+CD28+、CD4+CD44+、CD8+CD28+、CD8+CD44+ T细胞频率。
  • SB-1组和HVT组活化单核/巨噬细胞、CD4+CD8+双阳性细胞及CD4+MHC-II+细胞频率显著高于假接种对照组。
  • SB-1组CD4+ T细胞频率显著高于CVI-988组和对照组;与HVT相比,SB-1诱导更高活化单核/巨噬细胞和双阳性细胞频率。

核心结论

  • 三种疫苗(HVT、CVI-988和SB-1)似乎均增强一日龄肉型鸡的先天性和/或适应性应答,但这些疫苗的免疫协同作用需进一步研究。

研究设计与样本

  • 研究在18胚龄对肉型鸡进行胚内接种HVT、CVI-988或SB-1疫苗,并设假接种对照组,评估先天性与适应性免疫应答及CVI-988或SB-1与HVT的协同免疫增强效应。

主要发现

  • 与假接种对照组相比,三种疫苗均显著增加脾脏γδ T细胞、CD4+CD28+、CD4+CD44+、CD8+CD28+和CD8+CD44+ T细胞频率。
  • 活化单核/巨噬细胞、CD4+CD8+双阳性(DP)细胞和CD4+MHC-II+细胞频率在SB-1组和HVT组显著高于假接种对照组。
  • SB-1组CD4+ T细胞频率显著高于CVI-988组和对照组。
  • 与HVT组相比,SB-1组活化单核/巨噬细胞和DP细胞频率显著更高,而CVI-988组DP细胞、CD4+CD28+和CD4+CD44+ T细胞显著减少。
  • CVI-988与HVT联合在增强脾脏IFN-β和IFN-γ转录方面观察到协同效应,但对脾脏免疫表型变化无影响。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出这些疫苗的免疫协同作用需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We have previously demonstrated that in ovo vaccination with Herpesvirus of Turkey (HVT) at 18 days-of-embryonation (ED) accelerates innate and cell-mediated immunity in one-day-old meat- and egg-type chickens. We also reported differences in the splenic immunophenotypes of egg-type chickens following HVT, CVI-988, and SB-1 vaccination. In this study, using meat-type chickens, we further evaluated the effect of in ovo administration of CVI-988 or SB-1 on innate and adaptive immune responses when compared to HVT. Additionally, we also assessed the synergistic immunopotentiation effect, if any, of CVI-988 or SB-1 with HVT. Results showed that all three vaccines could significantly augment splenic frequencies of γδ T cells, CD4+CD28+, CD4+CD44+, CD8+CD28+, and CD8+CD44+ T cells compared to sham-inoculated chickens. However, vaccines differed on tissue tropism, ability to increase PHA-L driven wing-web thickness, and ability to increase the frequency of some immunophenotypes. The frequencies of activated monocytes/macrophages, CD4+CD8+ double-positive (DP) cells, and CD4+MHC-II+ cells were found significantly higher in SB-1 and HVT groups compared to sham-inoculated control. Additionally, SB-1 vaccination led to significantly increased frequency of CD4+ T cells compared to CVI-988 and control groups. Furthermore, in comparison to HVT, SB-1 induced significantly higher frequencies of activated monocytes/macrophages and DP cells, while the CVI-988 vaccination showed a significant reduction in DP cells, CD4+CD28+, and CD4+CD44+ T cells. Finally, the synergistic effect of CVI-988 and HVT was observed in relation to augmenting splenic transcription of IFN-β and IFN-γ, while no effect on the changes in splenic immunophenotypes was observed. Collectively, all three vaccines (HVT, CVI-988 and SB-1) seem to enhance innate and/or adaptive responses in day-old meat-type chickens; however, immune-synergism of these vaccines needs further investigation.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Boone AC, Gaghan C, Fares A, et al. Ability to accelerate innate and cell-mediated immune responses in meat-type chickens by in ovo vaccination with monovalent and bivalent Marek's disease vaccines. Vaccine. 2025. PMID: 41274027. doi:10.1016/j.vaccine.2025.128001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。